GLIMEPIRIDE 1mg. IP + METFORMIN 1000mg. IP

An antidiabetic drug that is used to prevent blood glucose levels from rising to very high levels. Increases the amount of insulin released by the pancreas to lower blood glucose. (Maria L.A.D. Lestari, 2011) Stimulates the pancreatic beta cells to release insulin. (Abdul Basit, 2012) Effectively reduces fasting plasma glucose, postprandial glucose, and glycosylated hemoglobin levels. (Abdul Basit, 2012) A valuable, cost-effective treatment option for managing type 2 diabetes mellitus. (Abdul Basit, 2012) Exhibits more potent glucose-lowering effects than glyburide. (Fahir Becić, 2003) Offers a lower risk of hypoglycemia and less weight gain compared to other sulfonylureas. (Abdul Basit, 2012) An alternative to other sulphonylureas in type 2 diabetes mellitus subjects not well controlled by diet alone. (H D Langtry, 1998) A beneficial therapy for the treatment of non-insulin-dependent (type II) diabetes mellitus. (Fahir Becić, 2003) Shows superior efficacy than metformin or glimepiride monotherapy in type 2 diabetes patients who had failed glucose control with metformin. (Hye-soon Kim, 2014) A well-tolerated and more effective drug for glycemic control in type 2 diabetic patients inadequately controlled by low-dose metformin monotherapy. (Hye-soon Kim, 2014)